Filtrar por año

Edwards SAPIEN 3 TAVR Receives FDA Approval For Low-Risk Patients
Leer la historia
Edwards Lifesciences Reports Second Quarter Results
Leer la historia
Edwards Lifesciences To Host Earnings Conference Call On July 23, 2019
Leer la historia
Edwards Comments On Updated TAVR National Coverage Determination
Leer la historia
Edwards Lifesciences To Present At The Goldman Sachs 40th Annual Global Healthcare Conference
Leer la historia